-
SUMMIT - Neratinib Basket Study (Multi-Institute, Nature 2018): MSK-IMPACT sequencing of 86 patients with HER2- and HER3-mutant cancers
- Description
This dataset contains summary data visualizations and clinical data from a broad sampling of HER2- and HER3-mutant tumors. The data was generated utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes tumor type (based on the opensource OncoTree ontology developed at MSK), mutation count, information about mutated genes, Amplification Status, Best objective response rate, Bubble...
- Subject
-
Breast NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellColorectal NeoplasmsDNA Mutational AnalysisEndometrial NeoplasmsEsophageal NeoplasmsGenes, erbBGenes, erbB-2MelanomaOvarian NeoplasmsPancreatic NeoplasmsSalivary Gland NeoplasmsSarcomaSkin NeoplasmsUrinary Bladder NeoplasmsUterine Cervical Neoplasms
- Access Rights
- Free to All
-
Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model
- Authors
- Price, Jessica C.Azizi, ElhamParvani, Jenny G.Shukla, Priyanka5 more author(s)...
- Description
Summary from GEO: "High grade serous ovarian cancer (HGSC) is the most common and deadly type of ovarian cancer, largely due to difficulties in early diagnosis and rapid metastasis throughout the peritoneal cavity. Previous studies have shown that expression of Notch3 correlates with worse prognosis and increased tumorigenic cell behaviors in HGSC. We investigated the mechanistic role of Notch3 in...
- Subject
-
CarcinogenesisCarcinoma, Ovarian EpithelialEpithelial CellsOvarian NeoplasmsReceptor, Notch3RNA-Seq
- Access Rights
- Free to All
-
Senescence induction dictates response and resistance to chemo- and immunotherapy in preclinical models of ovarian cancer
- Authors
- Paffenholz, Stella V.Salvagno, CamillaHo, Yu-juiLimjoco, Matthew10 more author(s)...
- Description
Summary from GEO: "High-grade serous ovarian carcinoma (HGSOC) is associated with a dismal prognosis. While most patients initially respond to platinum-based chemotherapy, they almost always acquire resistance, and only a small subset of HGSOC patients benefit from immune checkpoint blockade (ICB). To elucidate the disease mechanisms and factors underlying sensitivity and resistance to conventional...
- Subject
-
Carcinoma, Ovarian EpithelialCellular SenescenceHomologous RecombinationImmune Checkpoint InhibitorsOvarian Neoplasms
- Access Rights
- Free to All